Avro Life Science Patents

Patent portfolio assigned to Avro Life Science (verified via public assignee records). Estimated patent count: 1. Pre-clinical transdermal drug-delivery (skin patch) startup; no customers expected. Competitors are transdermal-patch peers named in TechCrunch coverage. Patent confirmed via Google Patents assignee 'Avro Life Sciences, Inc' (US10576043B2 'Transdermal drug delivery system').